Transcatheter edge-to-edge repair (TEER) with the PASCAL valve repair system is both safe and clinically effective in prohibitive-risk patients with degenerative mitral regurgitation (DMR) and complex valve anatomy, according to new 30-day and 6-month follow-up data.